Xenoantigen, an αGal epitope-expression construct driven by the hTERT-promoter, specifically kills human pancreatic cancer cell line

Xenoantigen, an αGal epitope-expression construct driven by the hTERT-promoter, specifically kills human pancreatic cancer cell line

<p>Abstract</p> <p>Background</p> <p>We previously reported the usefulness of the αGal epitope as a target molecule for gene therapy against cancer. To induce cancer cell specific transcription of the αGal epitope, an expression vector which synthesizes the αGal epitope...

Full description

Bibliographic Details
Main Authors: Fuchinoue Shohei, Hatori Keiko, Yoshimura Naoko, Yamada Osamu, Sawada Tokihiko, Teraoka Satoshi
Format: Article
Language:English
Published: BMC 2002-10-01
Series:Cancer Cell International
Online Access:http://www.cancerci.com/content/2/1/14

Internet

http://www.cancerci.com/content/2/1/14

Similar Items